Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

NCT01814475 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: A: Fludarabine + Busulphan
DRUG: B: Fludarabine + Thiotepa

Sponsor

Gruppo Italiano Trapianto di Midollo Osseo